长期氧疗在慢性阻塞性肺疾病缓解期疗效评价被引量：6

下载PDF

导出

摘要目的评价长期氧疗在慢性阻塞性肺疾病(COPD)缓解期治疗效果。方法将50例COPD缓解期患者随机分为两组,治疗组28例(其中1例中途死亡而终止),对照组22例(其中1例因COPD急性发作较重而退出,2例死亡而终止)。治疗组吸入钢瓶氧气,氧浓度(FIO2)27%,每日吸氧时间>15h,共计1年。治疗前后分别进行肺功能测定,体重、身高测量以及MMRC6、MWT测定,应用BODE指数、MMRC及6MWT评价方法进行疗效评价。结果治疗组BODE指数、MMRC均治疗前有所下降(BODE:P<0.01,MMRC:P<0.05),而对照组无改变(P>0.05),6MWT较治疗前有增加(P<0.01),而对照组无改善(P>0.05)。结论长期氧疗在改善COPD患者呼吸困难、活动耐受性以及降低死亡危险性方面有较好的效果。

作者赵碧双黄丹魏惠灵胥正川

机构地区中铁二局中心医院内科

出处《四川医学》 CAS 2007年第7期733-734,共2页 Sichuan Medical Journal

关键词肺疾病慢性阻塞性长期氧疗疗效评价

分类号 R563.9 [医药卫生—呼吸系统]

引文网络
相关文献

参考文献8

1Eaton T,Lewis C,Young P,et al.Long-term oxygen therapy improves health-related quality of life[J].Respiratory medicine,2004,4:285-293
2Cranston JM,Nguyen AM,Crockett AJ.The relative survival of COPD patients on long-term oxygen therapy in Australia:a comparative study[J].Respirology,2004,2:237-242
3皮秀杰,王甲宁,林志国.长期家庭氧疗在慢性阻塞性肺疾病的稳定期治疗中的价值[J].中华临床医药杂志（北京）,2004,5(9):77-78. 被引量：2
4慢性阻塞性肺疾病诊治指南[J].中华结核和呼吸杂志,2002,25(8):453-460. 被引量：5103
5陈美玉,汤彦.慢性阻塞性肺疾病疗效评估指标的现状与评价[J].中国实用内科杂志,2006,26(7):1023-1025. 被引量：12
6Mahler D,Wells C.Evaluation of clinical methods for rating dyspnea[J].Chest,1988,93(3):580-586
7Bartolome R Celli,Claudia G Cote,Jose M Marin,et al.The body-mass index,airflow obstruction,dyspnea,and exercise capacity index in chronic obstructive pulmonary disease[J].The New England Journal of Medicine,2004,350(10):1005-1012
8Nishimura K,Izumi T,Tsukino M,et al.Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD[J].Chest,2002,121(5):1434-1440

二级参考文献18

1温华,胡雪君,康健,刘刚,宋玉,于润江.慢性阻塞性肺疾病患者静态肺功能和弥散功能对运动能力的影响[J].中国实用内科杂志,2005,25(4):322-323. 被引量：3
2陈宇清,周新,陈钦,戴晓敏,楼旭军.稳定期慢性阻塞性肺疾病患者潮气呼吸肺功能测定的临床意义[J].中国实用内科杂志,2005,25(11):978-980. 被引量：3
3McCord M,Cronin-Stubbs D.Operationalizing dyspnea:focus on measurement[J].Heart Lung,1992,21:167-179.
4Guyatt G,Berman L,Townsend M,et al.A measure of quality of life for clinical trials in chronic lung disease[J].Thorax,1987,42:773-778.
5Mahler D,Weinberg D,Wells C,et al.The measurement of dyspnea:contents,interobserver agreement,and physiologic correlates of two new clinical indexes[J].Chest,1984,85:751-758.
6Mahler D,Wells C.Evaluation of clinical methods for rating dyspnea[J].Chest,1988,93:580-586.
7Nishimura K,Izumi T,Tsukino M,et al.Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD[J].Chest,2002,121:1434-1440.
8Casas A,Vilaro J,Rabinovich R,et al.Encouraged 6-min walking test indicates maximum sustainable exercise in COPD Patients[J].Chest,2005,128:55-61.
9Landbo C,Prescott E,Lange P,et al.Prognostic value of nutritional status in chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med,1999,160:1856 -1861.
10Garcia-Pachon E,Padilla-Navas I.Clinical implications of Hoover's sign in chronic obstructive pulmonary disease[J].Eur J Intern Med,2004,15:50 -53.